Home / News
-
-
Japanese healthcare firm Sysmex said that it has signed a global supply agreement for hemostasis instruments and reagents with Siemens Healthineers.2023-03-10View More
-
-
BioM¨¦rieux reported Wednesday that its fourth quarter revenues rose 11 percent year over year.2023-03-09View More
-
-
QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it has been granted a De Novo request from the U.S. Food and Drug Administration (FDA).2023-03-09View More
-
-
Recently, executives from multinational medical enterprises intensively visited China or revealed their plans to visit China. It is becoming a common question for most multinational medical businesses to explore how to support China's high-level opening up.2023-03-08View More
-
-
Spectrum Solutions® announced the acquisitions of Alimetrix, Inc., a CLIA and CAP accredited molecular diagnostic laboratory, and Microarrays, Inc., a leader in customer array-based products that are used as biological research tools.2023-03-08View More
-
-
Abbott announced on Tuesday that its laboratory-based test for traumatic brain injuries has received clearance from the US Food and Drug Administration.2023-03-08View More
-
-
TinkerBio completed a Series A+ financing round of tens of millions of RMB, exclusively invested by Panlin Capital.2023-03-07View More
-
-
MGI Tech said last week that it has signed the EU Declaration of Conformity for its DNBSeq-G99 sequencer, granting the instrument CE marking under Europe's new In Vitro Diagnostic Regulation (IVDR).2023-03-07View More
-
-
Roche announced on Monday that its Ventana PD-L1 (SP263) assay has received approval from the US Food and Drug Administration for use as a companion diagnostic with Regeneron's Libtayo (cemiplimab) in lung cancer patients.2023-03-07View More
-
-
Recently, U.S. Food and Drug Administration (FDA) and China National Medical Products Administration (NMPA) have released their summaries on medical device innovation in 2022.2023-03-06View More
-
-
The US Food and Drug Administration has allowed InBios International to market its point-of-care anthrax test, the firm announced this week.2023-03-06View More
-
-
BGI Genomics said on Friday that its multiplexed test for SARS-CoV-2, influenza A, and influenza B is now included in the Australian Register of Therapeutic Goods.2023-03-06View More
-
-
Recently, Sansure and Singlera jointly established Jiangsu Yang Shengyuan Biotechnology Co., Ltd. with the registered capital of 10 million CNY at Yangzhou City.2023-03-03View More
-
-
Illumina and Myriad Genetics said on Thursday that they have expanded their strategic partnership on homologous recombination deficiency (HRD) testing.2023-03-03View More
-
-
Biocartis said Thursday that it has secured US Food and Drug Administration 510(k) clearance for a microsatellite instability (MSI) assay to screen for Lynch syndrome in colorectal cancer patients.2023-03-03View More
-
-
By the end of 2022, there were 1,033,000 medical and health institutions in China, including 37,000 hospitals. The medical and health institutions in China possessed 9.75 million beds, of which hospitals possessed 7.66 million and township health centers had 1.45 million.2023-03-02View More
-
-
QIAGEN N.V. announced the launch of the new QIAseq Platform Partnership program and the first partnership with medical data-analysis provider SOPHiA GENETICSTM that will bring together its QIAseq reagent technology for next-generation sequencing with the SOPHiA DDMTM digital analytics platform.2023-03-02View More
-
-
Agilent Technologies reported after the close of the market that its fiscal first quarter revenues rose 5 percent year over year with gains across all end markets.2023-03-02View More
-
-
On February 26, Mindray and the First Affiliated Hospital of Guangxi Medical University held a signing ceremony at Mindray headquarters in Shenzhen and signed a strategic cooperation agreement.2023-03-01View More
-
-
Natera reported after the close of market Tuesday year-over-year revenue gains of approximately 26 percent for the fourth quarter of 2022 and 31 percent for the full year.2023-03-01View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.